Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 35, 2020 - Issue 1
Submit an article Journal homepage
1,286
Views
7
CrossRef citations to date
0
Altmetric
Article

Synthesis and structure-activity relationships of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives as 5-lipoxygenase inhibitors

Oludotun A. Phillipsa Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Kuwait University, Safat, KuwaitCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8350-7338View further author information
ORCID Icon,
Mira A. Bossob Faculty of Medicine, Department of Pharmacology & Toxicology, Kuwait University, Safat, KuwaitView further author information
&
Charles I. Ezeamuzieb Faculty of Medicine, Department of Pharmacology & Toxicology, Kuwait University, Safat, KuwaitCorrespondence[email protected]
View further author information
Pages 1471-1482 | Received 10 Apr 2020, Accepted 16 Jun 2020, Published online: 08 Jul 2020

References

  • Ferguson AD, McKeever BM, Xu S, et al. Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein. Science 2007;317:510–2.
  • Radmark O, Werz O, Steinhilber D, et al. 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem Sci 2007;32:332–41.
  • Hofmann B, Steinhilber D. 5-Lipoxygenase inhibitors: a review of recent patents (2010-2012). Expert Opin Ther Pat 2013;23:895–909.
  • Radmark O, Werz O, Steinhilber D, Samuelsson B. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. Biochim Biophys Acta 2015;1851:331–9.
  • Montuschi P. Leukotrienes, antileukotrienes and asthma. Mini Rev Med Chem 2008;8:647–56.
  • Riccioni G, Back M. Leukotrienes as modifiers of preclinical atherosclerosis? The Sci World J 2012;2012:490968.
  • Steinhilber D, Hofmann B. Recent advances in the search for novel 5-lipoxygenase inhibitors. Basic Clin Pharmacol Toxicol 2014;114:70–7.
  • Sarveswaran S, Chakraborty D, Chitale D, et al. Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells. J Biol Chem 2015;290:4994–5006.
  • Pergola C, Werz O. 5-Lipoxygenase inhibitors: a review of recent developments and patents. Expert Opin Ther Pat 2010;20:355–75.
  • Boudreau LH, Lassalle-Claux G, Cormier M, et al. New hydroxycinnamic acid esters as novel 5-lipoxygenase inhibitors that affect leukotriene biosynthesis. Mediators Inflamm 2017;2017:6904634.
  • Boschi D, Giorgis M, Cena C, et al. Multitarget drugs: synthesis and preliminary pharmacological characterization of zileuton analogues endowed with dual 5-LO inhibitor and NO-dependent activities. ChemMedChem 2010;5:1444–9.
  • Stewart AO, Bhatia PA, Martin JG, et al. Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors. J Med Chem 1997;40:1955–68.
  • Corey EJ, Cashman JR, Kantner SS, Wright SW. Rationally designed, potent competitive inhibitors of leukotriene biosynthesis. J Am Chem Soc 1984;106:1503–4.
  • Summers JB, Gunn BP, Mazdiyasni H, et al. In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase. J Med Chem 1987;30:2121–6.
  • Summers JB, Gunn BP, Martin JG, et al. Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis. J Med Chem 1988;31:1960–4.
  • Reck F, Zhou F, Girardot M, et al. Identification of 4-substituted 1,2,3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A. J Med Chem 2005;48:499–506.
  • Bolasco A, Carradori S, Fioravanti R. Focusing on new monoamine oxidase inhibitors. Expert Opin Ther Pat 2010;20:909–39.
  • Leach KL, Brickner SJ, Noe MC, Miller PF. Linezolid, the first oxazolidinone antibacterial agent. Ann N Y Acad Sci 2011;1222:49–54.
  • Pandit N, Singla RK, Shrivastava B. Current updates on oxazolidinone and its significance. Int J Med Chem 2012;2012:159285.
  • Phillips OA, Sharaf LH. Oxazolidinone antimicrobials: a patent review (2012-2015). Expert Opin Ther Pat 2016;26:591–605.
  • Kombian SB, Phillips OA. In vitro electrophysiological investigations of the acute effects of linezolid and novel oxazolidinones on central nervous system neurons. Neuroscience 2011;180:53–63.
  • Hedaya OM, Mathew PM, Mohamed FH, et al Antiproliferative activity of a series of 5-(1H-1,2,3-triazolyl) methyl- and 5-acetamidomethyl-oxazolidinone derivatives. Mol Med Rep 2016;13:3311–8.
  • Qaddoumi MG, Phillips OA, Kombian SB. A novel oxazolidinone derivative PH192 demonstrates anticonvulsant activity in vivo in rats and mice. Eur J Pharm Sci 2019;130:21–6.
  • Phillips OA, Udo EE, Ali AA, Al-Hassawi N. Synthesis and antibacterial activity of 5-substituted oxazolidinones. Bioorg Med Chem 2003;11:35–41.
  • Phillips OA, D’Silva R, Bahta TO, et al. Synthesis and biological evaluation of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives. Eur J Med Chem 2015;106:120–31.
  • Hanke T, Dehm F, Liening S, et al Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo. J Med Chem 2013;56:9031–44.
  • Adcock IM, Caramori G, Chung KF. New targets for drug development in asthma. Lancet 2008;372:1073–87.
  • Davis BJ, Flanagan BF, Gilfillan AM, et al. Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells. J Immunol 2004;173:6914–20.
  • Pufahl RA, Kasten TP, Hills R, et al. Development of a fluorescence-based enzyme assay of human 5-lipoxygenase. Anal Biochem 2007;364:204–12.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.